Dronedarone
| 證據等級: L5 | 預測適應症: 10 個 |
目錄
Dronedarone: Drug Repurposing Evaluation — Pending Indication Data
One-Sentence Summary
Dronedarone (DrugBank ID: DB04855) is a candidate drug entered into the TxGNN repurposing pipeline. The current Evidence Pack contains no TxGNN-predicted new indications and no recorded original indications, meaning a substantive repurposing assessment cannot be completed at this stage. The two blocking data gaps — mechanism of action and package insert safety data — must be resolved before evaluation can proceed.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not available in current Evidence Pack |
| Predicted New Indication | None generated |
| TxGNN Prediction Score | Not available |
| Evidence Level | L5 — model output pending |
| Taiwan Market Status | Not marketed |
| Number of Authorizations | 0 |
| Recommended Decision | Hold |
Conclusion and Next Steps
Decision: Hold
Rationale: The TxGNN pipeline has not produced any predicted indications for Dronedarone in this Evidence Pack version (v4, data cutoff 2026-04-20), and the two data gaps flagged as High/Blocking severity prevent both mechanistic analysis and safety pre-screening. There is no basis on which to evaluate repurposing potential at this time.
To proceed, the following is needed:
- [DG001 — Blocking] Retrieve and parse the official package insert (PDF) to extract warnings and contraindications — required for safety pre-screening (S1 gate)
- [DG002 — High] Query DrugBank API for mechanism of action (MOA) — required for mechanistic plausibility analysis
- Run TxGNN prediction for Dronedarone (DB04855) to generate at least one ranked indication candidate before this report template can be meaningfully populated
- Confirm original approved indication(s) from TFDA or equivalent regulatory source (the
original_indicationsfield is currently empty)Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.